Abcam, ab76323, Anti-MST1/MST2 (phospho T180 + T183) antibody [EPR1467Y]

Size: 100µL / 1mL
Rabbit Recombinant Monoclonal STK3/MST-2 antibody. Suitable for WB and reacts with Human samples. Cited in 10 publications.
Key facts
Host species:Rabbit,
Clonality:Monoclonal,
Clone number:EPR1467Y,
Isotype:IgG,
Carrier free:No,
Reacts with:Human,
Applications:WBSee reactivity dataSee the reactivity data table below for information on validated species and application combinations.,
Immunogen:The exact immunogen used to generate this antibody is proprietary information.

Product details:
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please
contact us
for more information.
Patented technology
Our RabMAb
technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to
RabMAb® patents
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- High batch-to-batch consistency and reproducibility
- Improved sensitivity and specificity
- Long-term security of supply
- Animal-free batch production
For more information, read more on
recombinant antibodies

Properties and Storage Information:
Form-Liquid, Purification technique-Affinity purification Protein A, Storage buffer-pH: 7.2 - 7.4Preservative: 0.05% Sodium azideConstituents: 50% Tissue culture supernatant, 40% Glycerol (glycerin, glycerine), 9.85% Tris glycine, 0.1% BSA, Shipped at conditions-Blue Ice, Appropriate short-term storage conditions-+4°C, Appropriate long-term storage conditions--20°C, Aliquoting information-Upon delivery aliquot, Storage information-Avoid freeze / thaw cycle

Supplementary Information:
This supplementary information is collated from multiple sources and compiled automatically.
The MST1/MST2 proteins also known as STK4 and STK3 play mechanical roles as serine/threonine kinases. Each protein has a molecular mass of around 56-58 kDa. They are expressed in many tissues with high levels noted in the liver pancreas and kidney. These proteins exist mainly in the cytoplasm and can translocate to the nucleus upon activation. Activation usually takes place through autophosphorylation at certain residues which further facilitates phosphorylation of downstream substrates.
Biological function summary
MST1/MST2 function as core components of the Hippo signaling pathway. They act in a kinase complex together with other proteins like SAV1 LATS1 and MOB1. Their activities involve regulating cell proliferation apoptosis and organ size control. By phosphorylating other signaling molecules they decide whether cells enter apoptosis or continue proliferating impacting cellular homeostasis. MST1/MST2 phosphorylation triggers a cascade that ultimately influences transcriptional control in the nucleus.
Pathways
Both MST1 and MST2 integrate into the Hippo and Ras signaling pathways. Within the Hippo pathway they phosphorylate large tumor suppressors such as LATS1 and LATS2 which then regulate the transcriptional co-activators YAP and TAZ. This interaction helps determine gene expression associated with cell growth and survival. Hippo pathway's role links with Ras signaling where unchecked activity can lead to oncogenesis. MST1/MST2 function connects with MAP kinase proteins that play parts in oncogenic and apoptotic balance.
MST1 and MST2 exhibit connections to cancer and neurodegenerative diseases. Their regulatory dysfunction can contribute to tumor development due to disrupted cellular homeostasis. Low expression or mutation in MST genes relates to multiple types of cancers including hepatocellular carcinoma. MST1 has an association with neurodegenerative conditions like Alzheimer's disease where its role involves apoptosis-related protein interactions including those with caspases. Proper MST1/MST2 function is essential for maintaining controlled cell growth and apoptosis to prevent such diseases.